🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to assess the comparative pharmacokinetics of telmisartan/HCTZ in two...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT02262572
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
To establish the bioequivalence of fixed dose combination of 40 mg telmisar...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT02262598
Treatments Being Tested
The survey is conducted to collect safety and effectiveness information in ...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 111
Start Date
2010-01
Trial ID
NCT01050062
Treatments Being Tested
The Efficacy of a Fixed Dose Combination of Telmisartan/S-Amlodipine on 24-...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2014-06
Trial ID
NCT02231788
Treatments Being Tested
To investigate the relative bioavailability of telmisartan respectively of ...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT02262793
Treatments Being Tested
This Post Marketing Surveillance (PMS) study aims to review the followings ...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 10
Start Date
2003-09
Trial ID
NCT00659607
The primary objective of this survey is to prospectively investigate safety...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT02242838
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of HB-1, ...
Status
Recruiting
Location
Paratus Clinical Research Canberra
Start Date
2026-06
Trial ID
NCT07499440
randomized, open-label, single dose, replicate crossover clinical trial to ...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2016-10-01
Trial ID
NCT03032315